NasdaqGS:CLBTSoftware
Cellebrite DI (NasdaqGS:CLBT) Valuation in Focus as Leadership Shifts and Contract Delays Temper Guidance
If you’ve had your eye on Cellebrite DI (NasdaqGS:CLBT), the company’s latest announcements just gave investors plenty to consider. After reporting improved earnings and revenue growth for the first half of 2025, Cellebrite delivered a cautious outlook for the next quarter. The company cited delays with government contracts and disruptions linked to recent executive changes. This combination of strong results and temporary challenges is sure to make anyone weighing their next move with the...